Basics Harmony Biosciences Holdings, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2B Activated in VL: True Average Daily Range Avg Daily Range: $0.80 | 2.14% Avg Daily Range (30 D): $0.46 | 1.33% Avg Daily Range (90 D): $0.54 | 1.63% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .47M Avg Daily Volume (90 D): .51M Trade Size Avg Trade Size (Sh.): 52 Avg Trade Size (Sh.) (30 D): 43 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 1,867 Avg Inst. Trade: $2.29M Avg Inst. Trade (30 D): $3.15M Avg Inst. Trade (90 D): $3.12M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.82M Avg Closing Trade (30 D): $4.03M Avg Closing Trade (90 D): $4.23M Avg Closing Volume: 77.37K     News Apr 8, 2025 @ 5:00 PM Developmental and Epileptic Encephalopathies Marke... Source: Delveinsight Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Oct 14, 2024 @ 2:46 PM Dravet Syndrome Drug Pipeline Research Report 2024... Source: Researchandmarkets.Com Aug 6, 2024 @ 12:45 PM Harmony Biosciences Holdings, Inc. (HRMY) Surpasse... Source: Zacks.Com Financials   TTM Q1 2025 Q4 2024 Basic EPS $2.67 $.79 $.87 Diluted EPS $2.62 $.78 $.85 Revenue $ 744.85M $ 184.73M $ 201.27M Gross Profit $ 583.53M $ 152.74M $ 146.86M Net Income / Loss $ 152.72M $ 45.56M $ 49.48M Operating Income / Loss $ 195.04M $ 56.25M $ 55.73M Cost of Revenue $ 161.33M $ 31.99M $ 54.41M Net Cash Flow $ 156.02M $ 36M $ 65.63M PE Ratio 14.10